<?xml version="1.0" encoding="UTF-8"?>
<fig id="fig1" position="float" orientation="portrait">
 <object-id pub-id-type="doi">10.7554/eLife.42496.002</object-id>
 <label>Figure 1.</label>
 <caption>
  <title>Phylogeny of dengue virus sequences and normalized antigenic distances.</title>
  <p>(
   <bold>A</bold>) Maximum likelihood phylogeny of the 
   <italic>E</italic> (envelope) gene from titered dengue viruses. Notably, each of the four serotypes contains substantial genetic diversity. (
   <bold>B</bold>) Pairwise antigenic distances were estimated by 
   <xref rid="bib21" ref-type="bibr">Katzelnick et al. (2015)</xref> using plaque reduction neutralization titers (PRNT50, see Materials and methods). Aggregated titer values are standardized such that the distance between autologous virus-serum pairs is 0, and each titer unit corresponds to a two-fold change in PRNT50 value. Light gray areas represent missing data. Larger values correspond to greater antigenic distance.
  </p>
 </caption>
 <graphic xlink:href="elife-42496-fig1" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <p content-type="supplemental-figure">
  <fig id="fig1s1" specific-use="child-fig" orientation="portrait" position="anchor">
   <object-id pub-id-type="doi">10.7554/eLife.42496.003</object-id>
   <label>Figure 1—figure supplement 1.</label>
   <caption>
    <title>Titer value symmetry.</title>
    <p>Some viruses have greater avidity overall, and some sera are more potent overall. We normalize for these row and column effects (
     <inline-formula>
      <math id="inf3">
       <mstyle displaystyle="true" scriptlevel="0">
        <mrow>
         <msub>
          <mi>v</mi>
          <mrow>
           <mi>i</mi>
          </mrow>
         </msub>
        </mrow>
       </mstyle>
      </math>
     </inline-formula> and 
     <inline-formula>
      <math id="inf4">
       <mstyle displaystyle="true" scriptlevel="0">
        <mrow>
         <msub>
          <mi>p</mi>
          <mrow>
           <mi>j</mi>
          </mrow>
         </msub>
        </mrow>
       </mstyle>
      </math>
     </inline-formula>, respectively) in the titer model. Once overall virus avidity and serum potency are accounted for, titers are roughly symmetric (i.e., 
     <inline-formula>
      <math id="inf5">
       <mrow>
        <msub>
         <mi>D</mi>
         <mrow>
          <mi>i</mi>
          <mo>⁢</mo>
          <mi>j</mi>
         </mrow>
        </msub>
        <mo>≈</mo>
        <msub>
         <mi>D</mi>
         <mrow>
          <mi>j</mi>
          <mo>⁢</mo>
          <mi>i</mi>
         </mrow>
        </msub>
       </mrow>
      </math>
     </inline-formula>).
    </p>
   </caption>
   <graphic xlink:href="elife-42496-fig1-figsupp1" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </fig>
 </p>
</fig>
